Sources: 12Gene Ontology See all sources |
Cellular components related to cleft lip according to GeneDecks:| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | cytoplasm | GO:005737 | INF | PDGFRA, PDSS2, SKI, EDN1, EGFR, AHCY | | 2 | cell surface | GO:009986 | 8.5 | TGFB2, TGFB3, TGFBR3, PVRL2, WNT3A, WNT5A | | 3 | proteinaceous extracellular matrix | GO:005578 | INF | BMP4, TGFBR3, WNT11, WNT3, WNT3A, WNT5A | | 4 | extracellular region | GO:005576 | INF | COL27A1, RSPO3, NOG, CRISPLD2, CRISPLD1, CRB2 | | 5 | extracellular space | GO:005615 | INF | TGFA, EGFR, EDN1, NOG, TNC, CCL2 |
Biological processes related to cleft lip according to GeneDecks: (show top 50)
(show all 73)
| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | cellular response to retinoic acid | GO:071300 | 11.0 | FZD7, OSR1, WNT11, WNT3, WNT3A, WNT5A | | 2 | odontogenesis of dentin-containing tooth | GO:042475 | 11.0 | TP63, GLI2, FGF10, JAG2, MSX1, LHX8 | | 3 | methionine biosynthetic process | GO:009086 | 11.0 | MTHFD1, MTHFR, MTRR, BHMT2, BHMT | | 4 | hair follicle morphogenesis | GO:031069 | 10.9 | TGFB2, TP63, FGFR2, FGF7, FGF10, FOXE1 | | 5 | embryonic limb morphogenesis | GO:030326 | 10.9 | PRRX1, SKI, PTCH1, TP63, GREM1, FGFR1 | | 6 | middle ear morphogenesis | GO:042474 | 10.8 | PRRX1, OSR1, EDN1, NOG, FGFR1, MSX1 | | 7 | embryonic cranial skeleton morphogenesis | GO:048701 | 10.8 | WNT9B, PRRX1, TFAP2A, TGFBR1, TWIST1, PDGFRA | | 8 | wound healing | GO:042060 | 10.7 | WNT5A, TGFBR1, TGFB2, TGFA, PDGFRA, NOG | | 9 | inner ear morphogenesis | GO:042472 | 10.6 | EPHB2, PRRX1, TFAP2A, SPRY2, MAFB, FGFR2 | | 10 | embryonic forelimb morphogenesis | GO:035115 | 10.6 | WNT7A, OSR1, TFAP2A, TWIST1, MSX2, MSX1 | | 11 | pituitary gland development | GO:021983 | 10.6 | NOG, GLI2, FGF10, CDH1, BMPR1A, BMP4 | | 12 | in utero embryonic development | GO:001701 | 10.5 | TWIST1, TGFB3, TGFBR1, WNT3A, WNT9B, MYH9 | | 13 | skeletal system development | GO:001501 | 10.5 | SOX4, TGFBR1, DSPP, NOG, TP63, GLI2 | | 14 | positive regulation of mesenchymal cell proliferation | GO:002053 | 10.5 | PRRX1, TP63, FGFR2, FGFR1, FGF9, BMPR1A | | 15 | palate development | GO:060021 | 10.5 | VAX1, OSR1, PRRX1, WNT11, WNT3A, WNT5A | | 16 | negative regulation of axon extension involved in axon guidance | GO:048843 | 10.4 | WNT5A, WNT3A, WNT3, RYK | | 17 | osteoblast differentiation | GO:001649 | 10.4 | WNT3A, BMP4, MSX2, FGF9, GLI2, NOG | | 18 | face morphogenesis | GO:060325 | 10.3 | TGFB3, TGFB2, TGFB1, SKI, NOG, MSX1 | | 19 | ureteric bud development | GO:001657 | 10.3 | OSR1, TCF21, TGFB1, FGFR2, FGFR1, BMP7 | | 20 | cartilage development | GO:051216 | 10.3 | WNT7A, WNT5A, PRRX1, EDN1, NOG, SATB2 | | 21 | neuron differentiation | GO:030182 | 10.3 | WNT9B, WNT5A, WNT3A, WNT3, WNT11, RYK | | 22 | cellular response to growth factor stimulus | GO:071363 | 10.2 | BMP4, PAX9, MSX2, FYN, TGFB1, TGFB3 | | 23 | response to estradiol stimulus | GO:032355 | 10.1 | WNT5A, STAT5B, STAT3, TGFB2, TGFB1, FGF10 | | 24 | frontal suture morphogenesis | GO:060364 | 10.1 | TGFB3, TGFB2, TGFB1, MSX2 | | 25 | positive regulation of SMAD protein import into nucleus | GO:060391 | 10.1 | TGFBR1, TGFB3, TGFB1, BMPR1A, BMP4 | | 26 | negative regulation of transcription from RNA polymerase II promoter | GO:000122 | 10.0 | NOG, SKI, EDN1, TWIST1, TGFB1, TGIF1 | | 27 | positive regulation of bone mineralization | GO:030501 | 10.0 | OSR1, TFAP2A, TGFB3, TGFB1, BMPR1A, BMP7 | | 28 | epithelial to mesenchymal transition | GO:001837 | 10.0 | WNT5A, TGFBR3, TGFBR1, TGFB2, TGFB1, NOG | | 29 | positive regulation of pathway-restricted SMAD protein phosphorylation | GO:010862 | 10.0 | TGFBR1, TGFB3, TGFB1, BMPR1A, BMP7, BMP4 | | 30 | pathway-restricted SMAD protein phosphorylation | GO:060389 | 9.9 | TGFBR3, TGFBR1, TGFB2, TGFB1, BMP7 | | 31 | negative regulation of transcription, DNA-dependent | GO:045892 | 9.9 | SUMO1, TGFB1, TFAP2A, RUNX2, SIX3, WNT11 | | 32 | negative regulation of apoptotic process | GO:043066 | 9.9 | TGFB2, TFAP2A, OSR1, SOX4, WNT11, WNT5A | | 33 | negative regulation of cell proliferation | GO:008285 | 9.8 | TGIF1, TFAP2A, SOX4, TGFB3, TGFB2, TGFB1 | | 34 | positive regulation of transcription, DNA-dependent | GO:045893 | 9.7 | PHF8, TGFB1, TGFB3, TGFBR1, TFAP2A, STAT3 | | 35 | positive regulation of epithelial cell proliferation | GO:050679 | 9.6 | NOG, EGFR, TGFA, TGFB1, OSR1, ERBB2 | | 36 | positive regulation of transcription from RNA polymerase II promoter | GO:045944 | 9.5 | TCF21, TFAP2A, TGFB3, TGFB1, TLR4, TWIST1 | | 37 | response to drug | GO:042493 | 8.8 | GAD1, ADAM17, SLC12A5, STAT3, TGIF1, TGFB2 | | 38 | canonical Wnt receptor signaling pathway | GO:060070 | INF | WNT8A, WNT7A, WNT5A, WNT3A, WNT3, WNT11 | | 39 | angiogenesis | GO:001525 | INF | TGFA, TGFB2, , EPHB2, EPHB3, MYH9 | | 40 | axon guidance | GO:007411 | INF | PVRL1, RYK, WNT3, WNT3A, WNT5A, EPHB2 | | 41 | positive regulation of cell division | GO:051781 | INF | TGFA, TGFB1, TGFB2, TGFB3, FGFR2, FGF9 | | 42 | odontogenesis | GO:042476 | INF | OSR1, TGFB3, TGFB2, ENAM, FGFR2, | | 43 | embryonic hindlimb morphogenesis | GO:035116 | INF | WNT7A, OSR1, TWIST1, , MSX2, MSX1 | | 44 | organ induction | GO:001759 | INF | FGFR1, , FGF3, FGF10, FGF1 | | 45 | lung morphogenesis | GO:060425 | INF | , SPRY2, NOG, TCF21, BMP4 | | 46 | positive regulation of cell proliferation | GO:008284 | INF | EDN1, EGFR, TGFB1, TGFB2, TGFBR1, SOX4 | | 47 | mesonephros development | GO:001823 | INF | OSR1, , FGF10, BMP7, BMP4 | | 48 | positive regulation of gene expression | GO:010628 | INF | WNT3, WNT11, OSR1, TFAP2A, TGFB2, TGFB1 | | 49 | fibroblast growth factor receptor signaling pathway | GO:008543 | INF | SPRY2, FGFR2, FGFR1, FGF9, , FGF7 | | 50 | BMP signaling pathway | GO:030509 | INF | SKI, NOG, , BMPR1A, BMP7, BMP4 |
Molecular functions related to cleft lip according to GeneDecks: (show all 12)
| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | protein binding | GO:005515 | INF | HEMGN, TWIST1, TLR4, TGFA, TGFB1, TGFB2 | | 2 | sequence-specific DNA binding | GO:043565 | 10.5 | GLI2, TP73, DLX4, NR6A1, TGIF1, TFAP2A | | 3 | homocysteine S-methyltransferase activity | GO:008898 | 10.5 | BHMT, BHMT2, MTR | | 4 | sequence-specific DNA binding transcription factor activity | GO:003700 | 10.4 | DLX4, DLX3, TBX22, TBX10, TP73, TGIF1 | | 5 | frizzled binding | GO:005109 | 10.3 | WNT8A, WNT5A, WNT3, RYK, RSPO3 | | 6 | receptor agonist activity | GO:048018 | 10.3 | WNT8A, WNT7A, WNT5A, WNT3A, WNT3, GREM1 | | 7 | type II transforming growth factor beta receptor binding | GO:005114 | 10.0 | TGFBR3, TGFBR1, TGFB3, TGFB2, TGFB1 | | 8 | type 2 fibroblast growth factor receptor binding | GO:005111 | INF | , FGF7, FGF18, FGF10 | | 9 | heparin binding | GO:008201 | INF | TGFBR3, RSPO3, CRISPLD2, CCL2, FGFR2, FGFR1 | | 10 | protein tyrosine kinase activity | GO:004713 | INF | EPHB2, , RYK, EGFR, ERBB2, FGFR2 | | 11 | growth factor activity | GO:008083 | INF | BMP4, TGFB3, TGFB2, TGFB1, TGFA, MANF | | 12 | protein homodimerization activity | GO:042803 | INF | NOG, PDGFRA, TWIST1, TGFB1, TGFB2, TFAP2A |
|